mcmasterinnovationpark.ca/blog/astrazeneca-moves-to-acquire-mcmaster-supported-fusion-pharmaceuticals-for-24-billion-us

Preview meta tags from the mcmasterinnovationpark.ca website.

Linked Hostnames

12

Thumbnail

Search Engine Appearance

Google

https://mcmasterinnovationpark.ca/blog/astrazeneca-moves-to-acquire-mcmaster-supported-fusion-pharmaceuticals-for-24-billion-us

AstraZeneca moves to acquire McMaster-supported Fusion Pharmaceuticals for $2.4 billion (US) — McMaster Innovation Park

A cancer therapy and diagnostics company that grew from a McMaster professor’s idea into a clinical-stage biopharmaceutical company is being acquired by global pharmaceuticals giant AstraZeneca in a deal valued at as much as $2.4 billion (US). Fusion Pharmaceuticals, which develops next-generation



Bing

AstraZeneca moves to acquire McMaster-supported Fusion Pharmaceuticals for $2.4 billion (US) — McMaster Innovation Park

https://mcmasterinnovationpark.ca/blog/astrazeneca-moves-to-acquire-mcmaster-supported-fusion-pharmaceuticals-for-24-billion-us

A cancer therapy and diagnostics company that grew from a McMaster professor’s idea into a clinical-stage biopharmaceutical company is being acquired by global pharmaceuticals giant AstraZeneca in a deal valued at as much as $2.4 billion (US). Fusion Pharmaceuticals, which develops next-generation



DuckDuckGo

https://mcmasterinnovationpark.ca/blog/astrazeneca-moves-to-acquire-mcmaster-supported-fusion-pharmaceuticals-for-24-billion-us

AstraZeneca moves to acquire McMaster-supported Fusion Pharmaceuticals for $2.4 billion (US) — McMaster Innovation Park

A cancer therapy and diagnostics company that grew from a McMaster professor’s idea into a clinical-stage biopharmaceutical company is being acquired by global pharmaceuticals giant AstraZeneca in a deal valued at as much as $2.4 billion (US). Fusion Pharmaceuticals, which develops next-generation

  • General Meta Tags

    6
    • title
      AstraZeneca moves to acquire McMaster-supported Fusion Pharmaceuticals for $2.4 billion (US) — McMaster Innovation Park
    • X-UA-Compatible
      IE=edge,chrome=1
    • viewport
      initial-scale=1
    • charset
      utf-8
    • Accept-CH
      Sec-CH-UA-Platform-Version, Sec-CH-UA-Model

  • Open Graph Meta Tags

    11
    • og:site_name
      McMaster Innovation Park
    • og:title
      AstraZeneca moves to acquire McMaster-supported Fusion Pharmaceuticals for $2.4 billion (US) — McMaster Innovation Park
    • og:latitude
      40.7207559
    • og:longitude
      -74.0007613
    • og:locality

  • Twitter Meta Tags

    5
    • twitter:title
      AstraZeneca moves to acquire McMaster-supported Fusion Pharmaceuticals for $2.4 billion (US) — McMaster Innovation Park
    • twitter:image
      http://static1.squarespace.com/static/5d092497da4404000171ee85/5d82247a7b682a4ae620573e/6605844dc0d04040d00bb107/1740520075097/Fusion-Pharmaceuticals-1-1024x605.jpg?format=1500w
    • twitter:url
      https://mcmasterinnovationpark.ca/blog/astrazeneca-moves-to-acquire-mcmaster-supported-fusion-pharmaceuticals-for-24-billion-us
    • twitter:card
      summary
    • twitter:description
      A cancer therapy and diagnostics company that grew from a McMaster professor’s idea into a clinical-stage biopharmaceutical company is being acquired by global pharmaceuticals giant AstraZeneca in a deal valued at as much as $2.4 billion (US). Fusion Pharmaceuticals, which develops next-generation

  • Item Prop Meta Tags

    10
    • name
      AstraZeneca moves to acquire McMaster-supported Fusion Pharmaceuticals for $2.4 billion (US) — McMaster Innovation Park
    • url
      https://mcmasterinnovationpark.ca/blog/astrazeneca-moves-to-acquire-mcmaster-supported-fusion-pharmaceuticals-for-24-billion-us
    • description
      A cancer therapy and diagnostics company that grew from a McMaster professor’s idea into a clinical-stage biopharmaceutical company is being acquired by global pharmaceuticals giant AstraZeneca in a deal valued at as much as $2.4 billion (US). Fusion Pharmaceuticals, which develops next-generation
    • thumbnailUrl
      http://static1.squarespace.com/static/5d092497da4404000171ee85/5d82247a7b682a4ae620573e/6605844dc0d04040d00bb107/1740520075097/Fusion-Pharmaceuticals-1-1024x605.jpg?format=1500w
    • image
      http://static1.squarespace.com/static/5d092497da4404000171ee85/5d82247a7b682a4ae620573e/6605844dc0d04040d00bb107/1740520075097/Fusion-Pharmaceuticals-1-1024x605.jpg?format=1500w

  • Link Tags

    10
    • alternate
      https://mcmasterinnovationpark.ca/blog?format=rss
    • canonical
      https://mcmasterinnovationpark.ca/blog/astrazeneca-moves-to-acquire-mcmaster-supported-fusion-pharmaceuticals-for-24-billion-us
    • icon
      https://images.squarespace-cdn.com/content/v1/5d092497da4404000171ee85/1572619262194-843GWK9WLBEWCGQ6E8SZ/favicon.ico?format=100w
    • image_src
      http://static1.squarespace.com/static/5d092497da4404000171ee85/5d82247a7b682a4ae620573e/6605844dc0d04040d00bb107/1740520075097/Fusion-Pharmaceuticals-1-1024x605.jpg?format=1500w
    • preconnect
      https://images.squarespace-cdn.com

Links

40